← Volver a los detalles del artículo Life style and quality of life in patients with metabolic syndrome and diabetes type 2

Pediatric patients with Type 2 Diabetes Mellitus will have a worse fatty acid profile associated with inflammation compared with patients with Metabolic Syndrome

A poor quality of life and worse disease control in the patients were associated with a poorer quality of life of the family, higher scores of anxiety and depression, and the

(1) original quantitative studies conducted during the COVID-19 outbreak, (2) patients with chronic disease (diabetes type 1 and type 2, hypertension, hyperlipi- demia, dyslipidemia,

The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled,

FINDRISC, Finnish Diabetes Risk Score; OGTT, Oral glucose tolerance test; SPREDIA-2, Screening PRE- diabetes and type 2 DIAbetes; T2DM, Type 2 diabetes mellitus; UDM,

Makino, “Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney

NSAIDs increase the risk of cardiovascular disease in the general population, and although there is little direct evidence for elevated cardiovascular risk with NSAIDs in people